ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

VYGR Voyager Therapeutics Inc

8.81
0.28 (3.28%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Voyager Therapeutics Inc VYGR NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.28 3.28% 8.81 13:00:09
始値 安値 高値 終値 前日終値
8.76 8.61 8.92 8.81 8.53
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2305:30GLOBEVoyager Therapeutics to Present Broad Set of Translational..
2024/4/1620:00GLOBEVoyager Therapeutics Announces Selection of Development..
2024/3/2705:01GLOBEVoyager Therapeutics Announces Inducement Grants Under..
2024/3/1320:00GLOBEVoyager Therapeutics Announces Appointment of Toby Ferguson..
2024/2/2906:01GLOBEVoyager Therapeutics Reports Fourth Quarter and Full Year..
2024/2/2906:00EDGAR2Form 8-K - Current report
2024/2/2621:00GLOBEVoyager Therapeutics Announces Selection of Gene Therapy..
2024/2/2306:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2205:16EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2205:13EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2121:00GLOBEVoyager Therapeutics Announces Fourth Quarter 2023..
2024/2/2105:11EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2021:00GLOBEVoyager Therapeutics Reports Robust Preclinical Activity in..
2024/2/1707:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1707:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1707:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0721:00GLOBEVoyager Therapeutics to Present at the Oppenheimer Annual..
2024/1/2006:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2006:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1806:20EDGAR2Form D - Notice of Exempt Offering of Securities
2024/1/1805:33EDGAR2Form 144 - Report of proposed sale of securities
2024/1/1805:21EDGAR2Form 144 - Report of proposed sale of securities
2024/1/0906:49EDGAR2Form 8-K - Current report
2024/1/0906:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/1/0512:45GLOBEVoyager Therapeutics Announces Pricing of Public Offering
2024/1/0507:20EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/1/0506:14GLOBEVoyager Therapeutics Announces Proposed Public Offering
2024/1/0321:00GLOBEVoyager Therapeutics to Present at the 42nd Annual J.P...
2024/1/0221:46DJNVoyager Therapeutics Shares Leap Premarket on Novartis..
2024/1/0221:05EDGAR2Form 8-K - Current report
2024/1/0221:00GLOBEVoyager Therapeutics Enters Capsid License Agreement and..
2023/12/0621:04EDGAR2Form 8-K - Current report
2023/12/0621:00GLOBEVoyager Therapeutics Announces Selection of Development..
2023/11/0706:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0706:01GLOBEVoyager Therapeutics Reports Third Quarter 2023 Financial..
2023/11/0706:00EDGAR2Form 8-K - Current report
2023/10/3020:00GLOBEVoyager Therapeutics Announces Third Quarter 2023 Conference..
2023/10/0305:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2520:00GLOBEVoyager Therapeutics to Present at the Chardan Genetic..
2023/9/1905:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/1602:57EDGAR2Form 144 - Report of proposed sale of securities
2023/9/0805:01GLOBEVoyager Therapeutics Announces Inducement Grants Under..
2023/8/3020:00GLOBEVoyager Therapeutics to Participate in Upcoming Investor..
2023/8/1705:18EDGAR2Form 8-K - Current report
2023/8/0905:01GLOBEVoyager Therapeutics Announces Inducement Grants Under..
2023/8/0721:00GLOBEVoyager Therapeutics Announces Appointment of Beth Shafer as..
2023/8/0320:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0320:00EDGAR2Form 8-K - Current report
2023/8/0320:00GLOBEVoyager Therapeutics Reports Second Quarter 2023 Financial..

最近閲覧した銘柄

Delayed Upgrade Clock